from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary: Dianthus Therapeutics, Inc. /DE/ quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
Dianthus Therapeutics, Inc. /DE/ Operating Lease, Liability, Current for the quarter ending 30 Sep 2025 was $217,000, a 30% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Current, Quarterly (USD)

Operating Lease, Liability, Current, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Operating Lease, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$217,000	-$94,000	-30%	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$211,000	-$166,000	-44%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$226,000	-$174,000	-44%	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q4 2024	$320,000	-$97,000	-23%	31 Dec 2024	10-Q	05 Nov 2025	2025	Q3
Q3 2024	$311,000	-$102,000	-25%	30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$377,000	+$377,000		30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$400,000	+$400,000		31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$417,000	+$67,000	+19%	31 Dec 2023	10-K	11 Mar 2025	2024	FY
Q3 2023	$413,000	-$3,208,000	-89%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$0	-$3,423,000	-100%	30 Jun 2023	10-Q	03 Aug 2023	2023	Q2
Q1 2023	$0	-$3,246,000	-100%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$350,000	+$350,000		31 Dec 2022	10-K	21 Mar 2024	2023	FY
Q3 2022	$3,621,000			30 Sep 2022	10-Q	03 Nov 2022	2022	Q3
Q2 2022	$3,423,000			30 Jun 2022	10-Q	04 Aug 2022	2022	Q2
Q1 2022	$3,246,000			31 Mar 2022	10-Q	16 May 2022	2022	Q1
Q4 2021	$0			31 Dec 2021	8-K	21 Dec 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.